Article
Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin.
Clinica chimica acta; international journal of clinical chemistry - 1 Jun 2001
Linder M W
Abstract excerpt
Warfarin is the therapeutic of choice for maintenance anticoagualtion therapy. A principle caveat of this medication is that the dosage required to achieve the desired therapeutic effect varies up to 120-fold between individuals. Currently, there are no reliable means of prospectively identifying which patients will require either unusually high or low dosages. This dilemma puts patients at risk of therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
